AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2014

Apr 8, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-04-04

Reporting Person: Schenkein David P (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-04	Stock option (right to buy)	$2.34	A	54546	Acquired	2022-04-05	Common stock (54546)	Direct

Footnotes

F1: This option was granted on April 6, 2012 for the purchase of 72,727 shares of common stock. The option vests as to 25% upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013. The performance criteria for the second performance milestone were met on April 4, 2014, resulting in the vesting of the option as to 36,364 shares, and the remaining 18,182 shares will vest on April 4, 2015.